Diyu Chen

640 total citations · 1 hit paper
26 papers, 383 citations indexed

About

Diyu Chen is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Diyu Chen has authored 26 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Surgery and 11 papers in Cancer Research. Recurrent topics in Diyu Chen's work include Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), RNA modifications and cancer (6 papers) and MicroRNA in disease regulation (5 papers). Diyu Chen is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), RNA modifications and cancer (6 papers) and MicroRNA in disease regulation (5 papers). Diyu Chen collaborates with scholars based in China, Madagascar and United States. Diyu Chen's co-authors include Jian Wu, Shusen Zheng, Yifan Jiang, Rongliang Tong, Yuhong Jiang, Junru Chen, Bo Ding, Zhen Lv, Beng Yang and Linping Cao and has published in prestigious journals such as Hepatology, Environmental Pollution and Environment International.

In The Last Decade

Diyu Chen

23 papers receiving 378 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune Evasion

2023 90 citations Da Man, Jiahua Lu et al. Advanced Science profile →

Peers

Countries citing papers authored by Diyu Chen

Since Specialization

Citations

This map shows the geographic impact of Diyu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diyu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diyu Chen more than expected).

Fields of papers citing papers by Diyu Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diyu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diyu Chen. The network helps show where Diyu Chen may publish in the future.

Co-authorship network of co-authors of Diyu Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Diyu Chen. A scholar is included among the top collaborators of Diyu Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diyu Chen. Diyu Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	STAT3 induced BRD9 activation promotes intrahepatic cholangiocarcinoma progression by enhancing CD36 controlled fatty acid metabolism 2025 ·Cancer Letters ·(unknown), Diyu Chen, Jie Li, Rui Yang, Jun Gao, Wei‐Feng Qu, Xiutao Fu, Weiren Liu, Zhen‐Bin Ding, Jian Zhou, Yongyong Shi, (unknown), (unknown), Zheng Tang	0
2	GPC3-based circular RNA vaccine suppresses hepatocellular carcinoma progression by activating adaptive immune responses 2025 ·Hepatology ·Yifan Jiang, (unknown), Tong Wu, Linping Cao, Guangming Xu, Jiwei Liu, (unknown), Chaofeng Ding, Beng Yang, Rongliang Tong, Diyu Chen, (unknown)	0
3	Transforming acidic coiled-coil-containing protein 3-mediated lipid metabolism reprogramming impairs CD8+ T-cell cytotoxicity in hepatocellular carcinoma 2025 ·Signal Transduction and Targeted Therapy ·Ying Li, (unknown), Dongdong Wang, Wei Du, (unknown), Xiaotian Shen, Xiang Mao, Yinghan Su, Lun–Xiu Qin, Diyu Chen, Hu‐Liang Jia	0
4	Thiostrepton suppresses intrahepatic cholangiocarcinoma progression via FOXM1-mediated tumor-associated macrophages reprogramming 2025 ·Translational Oncology ·(unknown), Yifan Jiang, Rongliang Tong, Bo Ding, (unknown), (unknown), (unknown), Zheng Tang, Diyu Chen, Jian Wu	3
5	Diverse RNA methylation patterns in neutrophils: key drivers in hepatocellular carcinoma 2024 ·Clinical & Translational Oncology ·Guangming Xu, Yifan Jiang, Zhenhua Tu, Yu Li, Xiaofeng Xu, Rongliang Tong, Nan Jiang, (unknown), Diyu Chen, Jian Wu	1
6	Evidence of promoting effects of 6:2 Cl-PFESA on hepatocellular carcinoma proliferation in humans: An ideal alternative for PFOS in terms of environmental health? 2024 ·Environment International ·(unknown), (unknown), Hangbiao Jin, Yuanchen Chen, Yifan Jiang, Weichen Zhang, Diyu Chen, Shusen Zheng, Linping Cao	23
7	Environment relevant exposure of perfluorooctanoic acid accelerates the growth of hepatocellular carcinoma cells through mammalian target of rapamycin (mTOR) signal pathway 2023 ·Environmental Pollution ·(unknown), Xiaoyan Wang, Hangbiao Jin, Yuanchen Chen, Yifan Jiang, (unknown), Diyu Chen, Shusen Zheng, Linping Cao	10
8	Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune Evasion breakdown → 2023 ·Advanced Science ·(unknown), Da Man, Jiahua Lu, Yifan Jiang, Bo Ding, Rong Su, Rongliang Tong, Junru Chen, Beng Yang, Shusen Zheng, Diyu Chen, Jian Wu	90
9	A novel immunogenic cell death-related genes signature for predicting prognosis, immune landscape and immunotherapy effect in hepatocellular carcinoma 2023 ·Journal of Cancer Research and Clinical Oncology ·Guangming Xu, Yifan Jiang, (unknown), (unknown), Xiaofeng Xu, Diyu Chen, (unknown)	5
10	ST6GALNAC4 promotes hepatocellular carcinogenesis by inducing abnormal glycosylation 2023 ·Journal of Translational Medicine ·Da Man, (unknown), Deguo Zhang, (unknown), Bo Ding, Hanqing Liu, Guangming Xu, Jiahua Lu, Junnan Ru, Rongliang Tong, Shusheng Zheng, Diyu Chen, Jian Wu	9
11	Antitumor mechanism of cannabidiol hidden behind cancer hallmarks 2023 ·Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·(unknown), Li Yu, Hanqing Liu, Diyu Chen, Jian Wu	12
12	N⁶‐methyladenosine‐modified circSTX6 promotes hepatocellular carcinoma progression by regulating the HNRNPD/ATF3 axis and encoding a 144 amino acid polypeptide 2023 ·Clinical and Translational Medicine ·(unknown), Junnan Ru, Yunhao Chen, Zhenan Ling, Hanqing Liu, Bo Ding, Yifan Jiang, Jun Ma, Deguo Zhang, (unknown), Yu Li, Fei Sun, Diyu Chen, Shusen Zheng, Jian Wu	25
13	Left-side vs. right-side hepatectomy for hilar cholangiocarcinoma: a meta-analysis 2021 ·World Journal of Surgical Oncology ·Wenxuan Wu, Qiyang Cheng, Junru Chen, Diyu Chen, Xiaode Feng, Jian Wu	8
14	Apolipoprotein B Is Associated With the Microenvironment of Cholangiocarcinoma 2021 ·Frontiers in Oncology ·Xiaofeng Xu, Diyu Chen, Xiaode Feng, (unknown), (unknown), (unknown), Deguo Zhang, Zhenan Ling, (unknown), Jian Wu	4
15	Ileo-ileal intussusception and gastrointestinal bleeding caused by incidental heterotopic pancreas: four case reports 2021 ·Annals of Translational Medicine ·Linping Cao, Wenxuan Wu, Diyu Chen, (unknown), Jian Wu, Shusen Zheng	3
16	<p>Five Hub Genes Can Be The Potential DNA Methylation Biomarkers For Cholangiocarcinoma Using Bioinformatics Analysis</p> 2019 ·OncoTargets and Therapy ·Diyu Chen, Hao Wu, Bin He, Yuejie Lu, Wenxuan Wu, Hua Liu, Xiaode Feng, (unknown), Jian Wu	10
17	PKM2 upregulation promotes malignancy and indicates poor prognosis for intrahepatic cholangiocarcinoma 2019 ·Clinics and Research in Hepatology and Gastroenterology ·(unknown), Wendi Hu, Zhen Lv, Hua Liu, Diyu Chen, (unknown), Jian Wu, Shusen Zheng	25
18	Targeting Mybbp1a suppresses HCC progression via inhibiting IGF1/AKT pathway by CpG islands hypo-methylation dependent promotion of IGFBP5 2019 ·EBioMedicine ·Xiaoyu Weng, Jingbang Wu, Zhen Lv, Chuanhui Peng, Junru Chen, Cheng Zhang, Bin He, Rongliang Tong, Wendi Hu, Chaofeng Ding, Linping Cao, Diyu Chen, Jian Wu, Shusen Zheng	24
19	Genome-Wide Methylation and Expression Profiling Identify Methylation-Associated Genes in Colorectal Cancer 2019 ·Epigenomics ·Xiaohui Sun, Diyu Chen, Ziqi Jin, Tianhui Chen, Aifen Lin, Hongchuan Jin, Yimin Zhu, Maode Lai	11
20	Cystic lymphangioma of pancreas 2018 ·Medicine ·Diyu Chen, Xiaode Feng, Zhen Lv, (unknown), Chaofeng Ding, Jian Wu	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact